SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'ID8'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CQE_A_FLPA1650_1 (PROTEIN(PROSTAGLANDIN H2SYNTHASE-1)) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.56A | 1cqeA-5ikrA:59.0 | 1cqeA-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1CQE_B_FLPB2650_1 (PROTEIN(PROSTAGLANDIN H2SYNTHASE-1)) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.56A | 1cqeB-5ikrA:59.2 | 1cqeB-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1EQG_A_IBPA701_1 (PROSTAGLANDIN H2SYNTHASE-1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 8 / 9 | VAL A 116ARG A 120VAL A 349TYR A 355LEU A 359ALA A 527SER A 530LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-3.8A)NoneID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.34A | 1eqgA-5ikrA:59.2 | 1eqgA-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1EQG_B_IBPB1701_1 (PROSTAGLANDIN H2SYNTHASE-1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 10 / 11 | VAL A 116ARG A 120VAL A 349SER A 353TYR A 355LEU A 359TYR A 385ALA A 527SER A 530LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.35A | 1eqgB-5ikrA:59.3 | 1eqgB-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1EQH_A_FLPA701_1 (PROSTAGLANDIN H2SYNTHASE-1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | VAL A 116ARG A 120VAL A 349TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527SER A 530LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.61A | 1eqhA-5ikrA:59.4 | 1eqhA-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1EQH_B_FLPB1701_1 (PROSTAGLANDIN H2SYNTHASE-1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | VAL A 116ARG A 120VAL A 349TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527SER A 530LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.64A | 1eqhB-5ikrA:59.4 | 1eqhB-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FE2_A_LAXA700_1 (PROSTAGLANDINENDOPEROXIDE HSYNTHASE-1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 10 | VAL A 116ARG A 120PHE A 205VAL A 228VAL A 344TYR A 348VAL A 349ASN A 375LEU A 531 | NoneID8 A 601 ( 4.4A)NoneNoneNoneNoneID8 A 601 (-3.9A)NoneID8 A 601 (-3.5A) | 0.40A | 1fe2A-5ikrA:58.1 | 1fe2A-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FE2_A_LAXA700_2 (PROSTAGLANDINENDOPEROXIDE HSYNTHASE-1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 12 | PHE A 209LEU A 352PHE A 381TYR A 385TRP A 387PHE A 518GLY A 526GLY A 533LEU A 534 | NoneID8 A 601 (-4.1A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)NoneID8 A 601 (-3.5A)NoneNone | 0.93A | 1fe2A-5ikrA:58.1 | 1fe2A-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FE2_A_LAXA700_2 (PROSTAGLANDINENDOPEROXIDE HSYNTHASE-1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | PHE A 209LEU A 352TYR A 355PHE A 381TYR A 385TRP A 387GLY A 526ALA A 527SER A 530GLY A 533LEU A 534 | NoneID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)NoneNone | 0.76A | 1fe2A-5ikrA:58.1 | 1fe2A-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1IGX_A_EPAA700_1 (PROSTAGLANDINENDOPEROXIDE HSYNTHASE-1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | PHE A 205PHE A 209LEU A 352TYR A 355PHE A 381TYR A 385TRP A 387GLY A 526ALA A 527SER A 530GLY A 533LEU A 534 | NoneNoneID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)NoneNone | 0.59A | 1igxA-5ikrA:57.8 | 1igxA-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PTH_A_SALA710_1 (PROSTAGLANDIN H2SYNTHASE-1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 7 / 7 | VAL A 116ARG A 120VAL A 349LEU A 352TYR A 355ALA A 527LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A) | 0.48A | 1pthA-5ikrA:58.5 | 1pthA-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PTH_B_SALB711_1 (PROSTAGLANDIN H2SYNTHASE-1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 7 / 7 | VAL A 116ARG A 120VAL A 349LEU A 352TYR A 355ALA A 527LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A) | 0.48A | 1pthB-5ikrA:58.5 | 1pthB-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PXX_A_DIFA701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 10 | VAL A 349LEU A 352LEU A 384TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.49A | 1pxxA-5ikrA:34.5 | 1pxxA-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PXX_A_DIFA701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 10 | VAL A 349LEU A 384TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 ( 4.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.28A | 1pxxA-5ikrA:34.5 | 1pxxA-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PXX_B_DIFB1701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 9 | VAL A 349LEU A 352LEU A 384TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.48A | 1pxxB-5ikrA:35.2 | 1pxxB-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PXX_C_DIFC2701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 10 / 12 | VAL A 349LEU A 352SER A 353TYR A 355LEU A 384TYR A 385TRP A 387VAL A 523GLY A 526SER A 530 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.47A | 1pxxC-5ikrA:34.2 | 1pxxC-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PXX_C_DIFC2701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | VAL A 349SER A 353TYR A 355LEU A 384TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.24A | 1pxxC-5ikrA:34.2 | 1pxxC-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PXX_D_DIFD3701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 10 | VAL A 349LEU A 352TYR A 355LEU A 384TYR A 385TRP A 387VAL A 523GLY A 526SER A 530 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.50A | 1pxxD-5ikrA:34.7 | 1pxxD-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1PXX_D_DIFD3701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 10 | VAL A 349TYR A 355LEU A 384TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530 | ID8 A 601 (-3.9A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.27A | 1pxxD-5ikrA:34.7 | 1pxxD-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AYL_A_FLPA1701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.39A | 2aylA-5ikrA:59.2 | 2aylA-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AYL_A_FLPA1701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 8 / 12 | VAL A 349LEU A 352TYR A 385TRP A 387PHE A 518GLY A 526ALA A 527SER A 530 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)NoneID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.80A | 2aylA-5ikrA:59.2 | 2aylA-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AYL_B_FLPB2701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.44A | 2aylB-5ikrA:59.4 | 2aylB-5ikrA:63.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VCV_G_ASDG1224_1 (GLUTATHIONES-TRANSFERASE A3) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 4 / 7 | PHE A 381LEU A 352LEU A 534PHE A 205 | NoneID8 A 601 (-4.1A)NoneNone | 0.98A | 2vcvG-5ikrA:undetectable | 2vcvG-5ikrA:17.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HS6_A_EPAA1_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | VAL A 116VAL A 349SER A 353TYR A 355TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 534 | NoneID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)None | 0.39A | 3hs6A-5ikrA:61.7 | 3hs6A-5ikrA:87.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HS6_B_EPAB1_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | PHE A 209GLY A 227TYR A 355ASN A 375ILE A 377PHE A 381TYR A 385GLY A 526ALA A 527SER A 530GLY A 533LEU A 534 | NoneNoneID8 A 601 (-3.8A)NoneNoneNoneID8 A 601 ( 3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)NoneNone | 0.28A | 3hs6B-5ikrA:61.8 | 3hs6B-5ikrA:87.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HS6_B_EPAB1_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 7 / 12 | PHE A 210TYR A 355ILE A 377PHE A 381GLY A 526ALA A 527SER A 530 | COH A 602 (-4.0A)ID8 A 601 (-3.8A)NoneNoneID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 1.30A | 3hs6B-5ikrA:61.8 | 3hs6B-5ikrA:87.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KK6_A_CELA701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 7 / 12 | GLN A 192VAL A 349LEU A 352TRP A 387PHE A 518GLY A 526SER A 530 | NoneID8 A 601 (-3.9A)ID8 A 601 (-4.1A)COH A 602 (-4.5A)NoneID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.85A | 3kk6A-5ikrA:57.1 | 3kk6A-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KK6_A_CELA701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 12 | GLN A 192VAL A 349LEU A 352TYR A 355LEU A 359TRP A 387GLY A 526ALA A 527SER A 530 | NoneID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneCOH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.58A | 3kk6A-5ikrA:57.1 | 3kk6A-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KK6_B_CELB1701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 8 / 12 | HIS A 90GLN A 192VAL A 349LEU A 352TRP A 387PHE A 518GLY A 526SER A 530 | NoneNoneID8 A 601 (-3.9A)ID8 A 601 (-4.1A)COH A 602 (-4.5A)NoneID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.94A | 3kk6B-5ikrA:57.1 | 3kk6B-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KK6_B_CELB1701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 12 | HIS A 90GLN A 192VAL A 349LEU A 352TYR A 355LEU A 359TRP A 387GLY A 526SER A 530 | NoneNoneID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneCOH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.70A | 3kk6B-5ikrA:57.1 | 3kk6B-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LN1_A_CELA682_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | HIS A 90GLN A 192VAL A 349TYR A 355LEU A 359TRP A 387ALA A 516VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | NoneNoneID8 A 601 (-3.9A)ID8 A 601 (-3.8A)NoneCOH A 602 (-4.5A)NoneID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.32A | 3ln1A-5ikrA:62.4 | 3ln1A-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LN1_B_CELB682_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | HIS A 90GLN A 192VAL A 349TYR A 355LEU A 359TRP A 387ALA A 516VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | NoneNoneID8 A 601 (-3.9A)ID8 A 601 (-3.8A)NoneCOH A 602 (-4.5A)NoneID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.31A | 3ln1B-5ikrA:62.5 | 3ln1B-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LN1_C_CELC682_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | HIS A 90VAL A 349TYR A 355LEU A 359TYR A 385TRP A 387ALA A 516VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | NoneID8 A 601 (-3.9A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)NoneID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.33A | 3ln1C-5ikrA:62.5 | 3ln1C-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LN1_C_CELC682_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 7 / 7 | ARG A 120GLN A 192SER A 353LEU A 384ARG A 513ILE A 517PHE A 518 | ID8 A 601 ( 4.4A)NoneID8 A 601 ( 4.7A)ID8 A 601 ( 4.8A)NoneNoneNone | 0.35A | 3ln1C-5ikrA:62.5 | 3ln1C-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LN1_D_CELD682_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | HIS A 90GLN A 192VAL A 349SER A 353TYR A 355LEU A 359TRP A 387ALA A 516VAL A 523GLY A 526ALA A 527LEU A 531 | NoneNoneID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)NoneCOH A 602 (-4.5A)NoneID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A) | 0.31A | 3ln1D-5ikrA:34.1 | 3ln1D-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3LN1_D_CELD682_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 5 / 5 | ARG A 120LEU A 384ARG A 513ILE A 517PHE A 518 | ID8 A 601 ( 4.4A)ID8 A 601 ( 4.8A)NoneNoneNone | 0.36A | 3ln1D-5ikrA:34.1 | 3ln1D-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8W_A_FLPA701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | VAL A 116ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527SER A 530LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.42A | 3n8wA-5ikrA:58.7 | 3n8wA-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8X_A_NIMA701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 10 / 12 | HIS A 90ARG A 120LEU A 352TYR A 355TYR A 385TRP A 387GLY A 526ALA A 527SER A 530LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.63A | 3n8xA-5ikrA:58.1 | 3n8xA-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8X_A_NIMA701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 12 | HIS A 90ARG A 120LEU A 352TYR A 385TRP A 387PHE A 518GLY A 526SER A 530LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-4.1A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)NoneID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.82A | 3n8xA-5ikrA:58.1 | 3n8xA-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8X_B_NIMB1701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 10 / 12 | HIS A 90ARG A 120LEU A 352TYR A 355LEU A 359TRP A 387GLY A 526ALA A 527SER A 530LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneCOH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.62A | 3n8xB-5ikrA:58.3 | 3n8xB-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8X_B_NIMB1701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 8 / 12 | LEU A 352TYR A 355LEU A 359TRP A 387PHE A 518GLY A 526SER A 530LEU A 531 | ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneCOH A 602 (-4.5A)NoneID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.80A | 3n8xB-5ikrA:58.3 | 3n8xB-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8X_B_NIMB1701_2 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 3 / 3 | VAL A 116VAL A 349SER A 353 | NoneID8 A 601 (-3.9A)ID8 A 601 ( 4.7A) | 0.19A | 3n8xB-5ikrA:58.3 | 3n8xB-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8Y_A_DIFA701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 10 / 11 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.47A | 3n8yA-5ikrA:34.2 | 3n8yA-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8Y_B_DIFB585_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | VAL A 344VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387GLY A 526ALA A 527LEU A 531LEU A 534 | NoneID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)None | 0.48A | 3n8yB-5ikrA:33.4 | 3n8yB-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8Y_B_SALB900_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 4 / 5 | VAL A 349LEU A 352TYR A 355ALA A 527 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)ID8 A 601 (-3.5A) | 0.56A | 3n8yB-5ikrA:33.4 | 3n8yB-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8Z_A_FLPA701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | VAL A 116ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527SER A 530LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.46A | 3n8zA-5ikrA:58.7 | 3n8zA-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3N8Z_B_FLPB1701_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 384TYR A 385TRP A 387GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.61A | 3n8zB-5ikrA:58.7 | 3n8zB-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NT1_A_NPSA5_1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.40A | 3nt1A-5ikrA:62.8 | 3nt1A-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3NT1_B_NPSB4_1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.42A | 3nt1B-5ikrA:63.0 | 3nt1B-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3PGH_A_FLPA701_1 (CYCLOOXYGENASE-2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | VAL A 116VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | NoneID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.48A | 3pghA-5ikrA:25.9 | 3pghA-5ikrA:87.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3PGH_B_FLPB701_1 (CYCLOOXYGENASE-2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 11 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387MET A 522VAL A 523GLY A 526ALA A 527 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-4.2A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A) | 0.49A | 3pghB-5ikrA:24.0 | 3pghB-5ikrA:87.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3PGH_D_FLPD701_1 (CYCLOOXYGENASE-2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.52A | 3pghD-5ikrA:26.0 | 3pghD-5ikrA:87.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RR3_A_FLRA700_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | VAL A 116ARG A 120VAL A 349TYR A 355LEU A 359TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.36A | 3rr3A-5ikrA:35.0 | 3rr3A-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RR3_B_FLRB700_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | VAL A 116ARG A 120VAL A 349TYR A 355LEU A 359TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.36A | 3rr3B-5ikrA:34.4 | 3rr3B-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RR3_C_FLRC700_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | VAL A 116ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.41A | 3rr3C-5ikrA:62.4 | 3rr3C-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3RR3_D_FLRD700_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | VAL A 116ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.42A | 3rr3D-5ikrA:34.2 | 3rr3D-5ikrA:88.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VW1_D_CVID301_1 (PUTATIVE REGULATORYPROTEIN) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 3 / 3 | TYR A 495MET A 522LEU A 508 | NoneID8 A 601 (-4.2A)None | 0.99A | 3vw1D-5ikrA:undetectable | 3vw1D-5ikrA:15.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COX_A_IMNA701_1 (CYCLOOXYGENASE-2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 10 / 12 | ARG A 120VAL A 349SER A 353TYR A 355LEU A 384VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.65A | 4coxA-5ikrA:24.3 | 4coxA-5ikrA:87.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COX_A_IMNA701_1 (CYCLOOXYGENASE-2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | ARG A 120VAL A 349SER A 353TYR A 355TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.51A | 4coxA-5ikrA:24.3 | 4coxA-5ikrA:87.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COX_B_IMNB701_1 (CYCLOOXYGENASE-2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 10 / 12 | ARG A 120VAL A 349SER A 353TYR A 355LEU A 384VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.64A | 4coxB-5ikrA:61.6 | 4coxB-5ikrA:87.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COX_B_IMNB701_1 (CYCLOOXYGENASE-2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | ARG A 120VAL A 349SER A 353TYR A 355TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.50A | 4coxB-5ikrA:61.6 | 4coxB-5ikrA:87.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COX_C_IMNC701_1 (CYCLOOXYGENASE-2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 10 / 12 | ARG A 120VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387VAL A 523SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.70A | 4coxC-5ikrA:16.7 | 4coxC-5ikrA:87.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COX_C_IMNC701_1 (CYCLOOXYGENASE-2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | ARG A 120VAL A 349SER A 353TYR A 355TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.49A | 4coxC-5ikrA:16.7 | 4coxC-5ikrA:87.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COX_D_IMND701_1 (CYCLOOXYGENASE-2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 10 / 12 | ARG A 120VAL A 349SER A 353TYR A 355LEU A 384VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.64A | 4coxD-5ikrA:33.8 | 4coxD-5ikrA:87.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4COX_D_IMND701_1 (CYCLOOXYGENASE-2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | ARG A 120VAL A 349SER A 353TYR A 355TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.50A | 4coxD-5ikrA:33.8 | 4coxD-5ikrA:87.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4E1G_A_LNLA701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | PHE A 205PHE A 209TYR A 355ASN A 375ILE A 377PHE A 381TYR A 385GLY A 526ALA A 527SER A 530GLY A 533LEU A 534 | NoneNoneID8 A 601 (-3.8A)NoneNoneNoneID8 A 601 ( 3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)NoneNone | 0.52A | 4e1gA-5ikrA:62.6 | 4e1gA-5ikrA:87.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4E1G_A_LNLA701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 6 / 12 | PHE A 210TYR A 355ILE A 377PHE A 381GLY A 526ALA A 527 | COH A 602 (-4.0A)ID8 A 601 (-3.8A)NoneNoneID8 A 601 (-3.5A)ID8 A 601 (-3.5A) | 1.33A | 4e1gA-5ikrA:62.6 | 4e1gA-5ikrA:87.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4E1G_A_LNLA701_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 4 / 5 | ARG A 120VAL A 349SER A 353MET A 522 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-4.2A) | 0.28A | 4e1gA-5ikrA:62.6 | 4e1gA-5ikrA:87.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4E1G_A_LNLA701_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 4 / 5 | VAL A 349LEU A 352SER A 353MET A 522 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-4.2A) | 0.71A | 4e1gA-5ikrA:62.6 | 4e1gA-5ikrA:87.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4E1G_B_LNLB701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 10 / 12 | ARG A 120PHE A 205PHE A 209TYR A 355ILE A 377PHE A 381TYR A 385ALA A 527SER A 530GLY A 533 | ID8 A 601 ( 4.4A)NoneNoneID8 A 601 (-3.8A)NoneNoneID8 A 601 ( 3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)None | 0.57A | 4e1gB-5ikrA:62.5 | 4e1gB-5ikrA:87.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4E1G_B_LNLB701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | ARG A 120PHE A 205PHE A 209TYR A 355ILE A 377PHE A 381TYR A 385GLY A 526ALA A 527GLY A 533LEU A 534 | ID8 A 601 ( 4.4A)NoneNoneID8 A 601 (-3.8A)NoneNoneID8 A 601 ( 3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)NoneNone | 0.25A | 4e1gB-5ikrA:62.5 | 4e1gB-5ikrA:87.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4E1G_B_LNLB701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 7 / 12 | ARG A 120PHE A 210TYR A 355ILE A 377PHE A 381GLY A 526ALA A 527 | ID8 A 601 ( 4.4A)COH A 602 (-4.0A)ID8 A 601 (-3.8A)NoneNoneID8 A 601 (-3.5A)ID8 A 601 (-3.5A) | 1.41A | 4e1gB-5ikrA:62.5 | 4e1gB-5ikrA:87.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4E1G_B_LNLB701_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 6 / 7 | VAL A 344TYR A 348VAL A 349ASN A 375MET A 522VAL A 523 | NoneNoneID8 A 601 (-3.9A)NoneID8 A 601 (-4.2A)ID8 A 601 (-3.6A) | 0.20A | 4e1gB-5ikrA:62.5 | 4e1gB-5ikrA:87.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4E1G_B_LNLB701_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 6 / 7 | VAL A 344TYR A 348VAL A 349LEU A 352ASN A 375MET A 522 | NoneNoneID8 A 601 (-3.9A)ID8 A 601 (-4.1A)NoneID8 A 601 (-4.2A) | 0.58A | 4e1gB-5ikrA:62.5 | 4e1gB-5ikrA:87.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M11_A_MXMA606_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | MET A 113LEU A 117ARG A 120ILE A 345VAL A 349LEU A 352LEU A 359TRP A 387MET A 522ALA A 527SER A 530 | NoneNoneID8 A 601 ( 4.4A)NoneID8 A 601 (-3.9A)ID8 A 601 (-4.1A)NoneCOH A 602 (-4.5A)ID8 A 601 (-4.2A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.55A | 4m11A-5ikrA:62.4 | 4m11A-5ikrA:88.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M11_B_MXMB606_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 7 / 12 | MET A 113VAL A 116ARG A 120ILE A 345ALA A 527LEU A 531LEU A 534 | NoneNoneID8 A 601 ( 4.4A)NoneID8 A 601 (-3.5A)ID8 A 601 (-3.5A)None | 1.02A | 4m11B-5ikrA:62.4 | 4m11B-5ikrA:88.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M11_B_MXMB606_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | MET A 113VAL A 116ARG A 120ILE A 345VAL A 349LEU A 352LEU A 359TRP A 387ALA A 527SER A 530LEU A 534 | NoneNoneID8 A 601 ( 4.4A)NoneID8 A 601 (-3.9A)ID8 A 601 (-4.1A)NoneCOH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)None | 0.58A | 4m11B-5ikrA:62.4 | 4m11B-5ikrA:88.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M11_C_MXMC606_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 10 / 12 | MET A 113ILE A 345VAL A 349LEU A 352LEU A 359TRP A 387VAL A 523ALA A 527SER A 530LEU A 534 | NoneNoneID8 A 601 (-3.9A)ID8 A 601 (-4.1A)NoneCOH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)None | 0.42A | 4m11C-5ikrA:37.0 | 4m11C-5ikrA:88.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M11_C_MXMC606_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 10 / 12 | MET A 113VAL A 116ILE A 345VAL A 349LEU A 359TRP A 387VAL A 523ALA A 527SER A 530LEU A 534 | NoneNoneNoneID8 A 601 (-3.9A)NoneCOH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)None | 0.49A | 4m11C-5ikrA:37.0 | 4m11C-5ikrA:88.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M11_C_MXMC606_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 3 / 3 | LEU A 117ARG A 120MET A 522 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-4.2A) | 0.45A | 4m11C-5ikrA:37.0 | 4m11C-5ikrA:88.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M11_D_MXMD606_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 10 / 12 | MET A 113ARG A 120ILE A 345VAL A 349LEU A 352LEU A 359TRP A 387VAL A 523ALA A 527SER A 530 | NoneID8 A 601 ( 4.4A)NoneID8 A 601 (-3.9A)ID8 A 601 (-4.1A)NoneCOH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.46A | 4m11D-5ikrA:62.4 | 4m11D-5ikrA:88.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4M11_D_MXMD606_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 10 / 12 | MET A 113VAL A 116ILE A 345VAL A 349LEU A 352LEU A 359TRP A 387VAL A 523ALA A 527SER A 530 | NoneNoneNoneID8 A 601 (-3.9A)ID8 A 601 (-4.1A)NoneCOH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.57A | 4m11D-5ikrA:62.4 | 4m11D-5ikrA:88.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O1Z_A_MXMA807_2 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 6 / 6 | VAL A 116LEU A 117ARG A 120LEU A 359PHE A 518MET A 522 | NoneNoneID8 A 601 ( 4.4A)NoneNoneID8 A 601 (-4.2A) | 0.79A | 4o1zA-5ikrA:58.8 | 4o1zA-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O1Z_B_MXMB807_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | MET A 113VAL A 116LEU A 117ARG A 120ILE A 345VAL A 349LEU A 359TRP A 387PHE A 518ALA A 527SER A 530 | NoneNoneNoneID8 A 601 ( 4.4A)NoneID8 A 601 (-3.9A)NoneCOH A 602 (-4.5A)NoneID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.73A | 4o1zB-5ikrA:58.8 | 4o1zB-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O1Z_B_MXMB807_1 (PROSTAGLANDIN G/HSYNTHASE 1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 8 / 12 | MET A 113VAL A 116LEU A 117ARG A 120TRP A 387PHE A 518ALA A 527LEU A 531 | NoneNoneNoneID8 A 601 ( 4.4A)COH A 602 (-4.5A)NoneID8 A 601 (-3.5A)ID8 A 601 (-3.5A) | 0.97A | 4o1zB-5ikrA:58.8 | 4o1zB-5ikrA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OTY_A_LURA705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 10 / 12 | VAL A 349LEU A 352SER A 353TYR A 355LEU A 384VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.63A | 4otyA-5ikrA:34.1 | 4otyA-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OTY_A_LURA705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.42A | 4otyA-5ikrA:34.1 | 4otyA-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OTY_B_LURB705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | VAL A 349LEU A 352SER A 353TYR A 355LEU A 384TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.60A | 4otyB-5ikrA:34.1 | 4otyB-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OTY_B_LURB705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.40A | 4otyB-5ikrA:34.1 | 4otyB-5ikrA:88.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PH9_A_IBPA601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 10 | VAL A 116ARG A 120VAL A 349TYR A 355LEU A 359TRP A 387ALA A 527SER A 530LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-3.8A)NoneCOH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.62A | 4ph9A-5ikrA:63.0 | 4ph9A-5ikrA:88.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PH9_A_IBPA601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 10 | VAL A 116ARG A 120VAL A 349TYR A 355LEU A 359TRP A 387GLY A 526ALA A 527LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-3.8A)NoneCOH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A) | 0.32A | 4ph9A-5ikrA:63.0 | 4ph9A-5ikrA:88.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PH9_B_IBPB601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 10 | VAL A 116ARG A 120VAL A 349TYR A 355LEU A 359TRP A 387ALA A 527SER A 530LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-3.8A)NoneCOH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.60A | 4ph9B-5ikrA:62.9 | 4ph9B-5ikrA:88.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4PH9_B_IBPB601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 10 | VAL A 116ARG A 120VAL A 349TYR A 355LEU A 359TRP A 387GLY A 526ALA A 527LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-3.8A)NoneCOH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A) | 0.29A | 4ph9B-5ikrA:62.9 | 4ph9B-5ikrA:88.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRW_A_LURA705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387MET A 522VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-4.2A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.43A | 4rrwA-5ikrA:62.4 | 4rrwA-5ikrA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRW_B_LURB705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387MET A 522VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-4.2A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.43A | 4rrwB-5ikrA:35.9 | 4rrwB-5ikrA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRW_C_LURC705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.43A | 4rrwC-5ikrA:62.4 | 4rrwC-5ikrA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRW_C_LURC705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 12 | VAL A 349SER A 353TYR A 355LEU A 384VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.54A | 4rrwC-5ikrA:62.4 | 4rrwC-5ikrA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRW_D_LURD705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.48A | 4rrwD-5ikrA:62.5 | 4rrwD-5ikrA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRW_D_LURD705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 12 | VAL A 349SER A 353TYR A 355LEU A 384VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.59A | 4rrwD-5ikrA:62.5 | 4rrwD-5ikrA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRX_A_LURA706_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | TYR A 348VAL A 349LEU A 352TYR A 355LEU A 384TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | NoneID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.48A | 4rrxA-5ikrA:61.8 | 4rrxA-5ikrA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRX_B_LURB706_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | TYR A 348VAL A 349LEU A 352TYR A 355LEU A 384TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | NoneID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.54A | 4rrxB-5ikrA:62.0 | 4rrxB-5ikrA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRZ_A_LURA705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387MET A 522VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-4.2A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.43A | 4rrzA-5ikrA:62.4 | 4rrzA-5ikrA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRZ_B_LURB705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387MET A 522VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-4.2A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.43A | 4rrzB-5ikrA:35.9 | 4rrzB-5ikrA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRZ_C_LURC705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.43A | 4rrzC-5ikrA:62.4 | 4rrzC-5ikrA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRZ_C_LURC705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 12 | VAL A 349SER A 353TYR A 355LEU A 384VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.54A | 4rrzC-5ikrA:62.4 | 4rrzC-5ikrA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRZ_D_LURD705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | VAL A 349LEU A 352SER A 353TYR A 355TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.48A | 4rrzD-5ikrA:62.5 | 4rrzD-5ikrA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RRZ_D_LURD705_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 12 | VAL A 349SER A 353TYR A 355LEU A 384VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.59A | 4rrzD-5ikrA:62.5 | 4rrzD-5ikrA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RS0_A_IBPA706_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 8 / 9 | ARG A 120VAL A 349SER A 353TYR A 355LEU A 359GLY A 526ALA A 527LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)NoneID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A) | 0.34A | 4rs0A-5ikrA:36.7 | 4rs0A-5ikrA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4RS0_A_IBPA706_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 8 / 9 | VAL A 349LEU A 352SER A 353TYR A 355LEU A 359GLY A 526ALA A 527LEU A 531 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)NoneID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A) | 0.48A | 4rs0A-5ikrA:36.7 | 4rs0A-5ikrA:87.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5F1A_A_SALA601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 8 / 8 | VAL A 349LEU A 352LEU A 384TYR A 385TRP A 387GLY A 526ALA A 527SER A 530 | ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.36A | 5f1aA-5ikrA:63.7 | 5f1aA-5ikrA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5F1A_B_SALB601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 7 / 7 | VAL A 349LEU A 384TYR A 385TRP A 387GLY A 526ALA A 527SER A 530 | ID8 A 601 (-3.9A)ID8 A 601 ( 4.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A) | 0.18A | 5f1aB-5ikrA:63.6 | 5f1aB-5ikrA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IKQ_A_JMSA602_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 384TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.40A | 5ikqA-5ikrA:63.6 | 5ikqA-5ikrA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IKQ_A_JMSA602_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 3 / 3 | VAL A 116SER A 353MET A 522 | NoneID8 A 601 ( 4.7A)ID8 A 601 (-4.2A) | 0.27A | 5ikqA-5ikrA:63.6 | 5ikqA-5ikrA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IKQ_B_JMSB602_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 384TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)ID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.36A | 5ikqB-5ikrA:63.9 | 5ikqB-5ikrA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IKT_A_TLFA601_0 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | VAL A 116ARG A 120VAL A 349SER A 353TYR A 355LEU A 384TRP A 387MET A 522VAL A 523GLY A 526ALA A 527LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)ID8 A 601 ( 4.8A)COH A 602 (-4.5A)ID8 A 601 (-4.2A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A) | 0.32A | 5iktA-5ikrA:64.6 | 5iktA-5ikrA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IKT_A_TLFA601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 3 / 3 | LEU A 352TYR A 385SER A 530 | ID8 A 601 (-4.1A)ID8 A 601 ( 3.5A)ID8 A 601 (-2.7A) | 0.06A | 5iktA-5ikrA:64.6 | 5iktA-5ikrA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IKT_B_TLFB601_0 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | VAL A 116ARG A 120VAL A 349LEU A 352SER A 353LEU A 384TRP A 387MET A 522VAL A 523GLY A 526ALA A 527LEU A 531 | NoneID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 ( 4.8A)COH A 602 (-4.5A)ID8 A 601 (-4.2A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A) | 0.20A | 5iktB-5ikrA:64.8 | 5iktB-5ikrA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IKT_B_TLFB601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 3 / 3 | TYR A 355TYR A 385SER A 530 | ID8 A 601 (-3.8A)ID8 A 601 ( 3.5A)ID8 A 601 (-2.7A) | 0.13A | 5iktB-5ikrA:64.8 | 5iktB-5ikrA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JVZ_A_FLPA601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | ARG A 120VAL A 349LEU A 352TYR A 355LEU A 359TYR A 385TRP A 387VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.61A | 5jvzA-5ikrA:62.5 | 5jvzA-5ikrA:87.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JVZ_B_FLPB601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | ARG A 120VAL A 349LEU A 352SER A 353TYR A 355LEU A 359TYR A 385TRP A 387GLY A 526ALA A 527SER A 530LEU A 531 | ID8 A 601 ( 4.4A)ID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)NoneID8 A 601 ( 3.5A)COH A 602 (-4.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.60A | 5jvzB-5ikrA:62.2 | 5jvzB-5ikrA:87.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JW1_A_CELA602_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | HIS A 90GLN A 192VAL A 349TYR A 355LEU A 359TRP A 387ALA A 516VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | NoneNoneID8 A 601 (-3.9A)ID8 A 601 (-3.8A)NoneCOH A 602 (-4.5A)NoneID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.44A | 5jw1A-5ikrA:61.3 | 5jw1A-5ikrA:87.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JW1_A_CELA602_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 5 / 6 | LEU A 352SER A 353ARG A 513ILE A 517PHE A 518 | ID8 A 601 (-4.1A)ID8 A 601 ( 4.7A)NoneNoneNone | 0.58A | 5jw1A-5ikrA:61.3 | 5jw1A-5ikrA:87.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JW1_A_CELA602_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 5 / 6 | VAL A 116SER A 353ARG A 513ILE A 517PHE A 518 | NoneID8 A 601 ( 4.7A)NoneNoneNone | 0.28A | 5jw1A-5ikrA:61.3 | 5jw1A-5ikrA:87.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JW1_B_CELB602_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 9 / 12 | HIS A 90ARG A 120GLN A 192TYR A 355LEU A 359TRP A 387ALA A 516GLY A 526ALA A 527 | NoneID8 A 601 ( 4.4A)NoneID8 A 601 (-3.8A)NoneCOH A 602 (-4.5A)NoneID8 A 601 (-3.5A)ID8 A 601 (-3.5A) | 0.82A | 5jw1B-5ikrA:61.1 | 5jw1B-5ikrA:87.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JW1_B_CELB602_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | HIS A 90GLN A 192LEU A 352TYR A 355LEU A 359TRP A 387ALA A 516VAL A 523GLY A 526ALA A 527LEU A 531 | NoneNoneID8 A 601 (-4.1A)ID8 A 601 (-3.8A)NoneCOH A 602 (-4.5A)NoneID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A) | 0.49A | 5jw1B-5ikrA:61.1 | 5jw1B-5ikrA:87.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JW1_B_CELB602_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 6 / 6 | VAL A 116VAL A 349SER A 353ARG A 513ILE A 517PHE A 518 | NoneID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)NoneNoneNone | 0.35A | 5jw1B-5ikrA:61.1 | 5jw1B-5ikrA:87.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KIR_A_RCXA601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | HIS A 90GLN A 192VAL A 349LEU A 352TYR A 355TRP A 387ALA A 516VAL A 523ALA A 527SER A 530LEU A 531 | NoneNoneID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)COH A 602 (-4.5A)NoneID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.68A | 5kirA-5ikrA:63.0 | 5kirA-5ikrA:99.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KIR_A_RCXA601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 11 / 12 | HIS A 90GLN A 192VAL A 349LEU A 352TYR A 355TRP A 387ALA A 516VAL A 523GLY A 526ALA A 527LEU A 531 | NoneNoneID8 A 601 (-3.9A)ID8 A 601 (-4.1A)ID8 A 601 (-3.8A)COH A 602 (-4.5A)NoneID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A) | 0.45A | 5kirA-5ikrA:63.0 | 5kirA-5ikrA:99.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KIR_B_RCXB601_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 12 / 12 | HIS A 90GLN A 192VAL A 349SER A 353TYR A 355TRP A 387ALA A 516VAL A 523GLY A 526ALA A 527SER A 530LEU A 531 | NoneNoneID8 A 601 (-3.9A)ID8 A 601 ( 4.7A)ID8 A 601 (-3.8A)COH A 602 (-4.5A)NoneID8 A 601 (-3.6A)ID8 A 601 (-3.5A)ID8 A 601 (-3.5A)ID8 A 601 (-2.7A)ID8 A 601 (-3.5A) | 0.53A | 5kirB-5ikrA:63.8 | 5kirB-5ikrA:99.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KIR_B_RCXB601_2 (PROSTAGLANDIN G/HSYNTHASE 2) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 4 / 4 | LEU A 352ARG A 513ILE A 517PHE A 518 | ID8 A 601 (-4.1A)NoneNoneNone | 0.68A | 5kirB-5ikrA:63.8 | 5kirB-5ikrA:99.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HD6_A_STIA603_1 (TYROSINE-PROTEINKINASE ABL1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 4 / 5 | LEU A 472ILE A 452MET A 522GLY A 519 | NoneNoneID8 A 601 (-4.2A)None | 1.07A | 6hd6A-5ikrA:undetectable | 6hd6A-5ikrA:10.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HD6_A_STIA603_1 (TYROSINE-PROTEINKINASE ABL1) |
5ikr | PROSTAGLANDIN G/HSYNTHASE 2 (Homosapiens) | 4 / 5 | TYR A 475ILE A 452MET A 522GLY A 519 | NoneNoneID8 A 601 (-4.2A)None | 1.06A | 6hd6A-5ikrA:undetectable | 6hd6A-5ikrA:10.31 |